<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ep-patent-document PUBLIC "-//EPO//EP PATENT DOCUMENT 1.1//EN" "ep-patent-document-v1-1.dtd">
<ep-patent-document id="EP94916373B8W1" file="EP94916373W1B8.xml" lang="en" country="EP" doc-number="0702683" kind="B8" correction-code="W1" date-publ="20040908" status="c" dtd-version="ep-patent-document-v1-1">
<SDOBI lang="en"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESI............................................</B001EP><B003EP>*</B003EP><B005EP>J</B005EP><B007EP>DIM350 (Ver 2.1 Jan 2001)
 2610000/0 2999001/0</B007EP><B078EP><date>20040618</date></B078EP></eptags></B000><B100><B110>0702683</B110><B120><B121>CORRECTED EUROPEAN PATENT SPECIFICATION</B121></B120><B130>B8</B130><B132EP>B1</B132EP><B140><date>20040908</date></B140><B150><B151>W1</B151><B153>72</B153><B155><B1551>DE</B1551><B1552>Bibliographie</B1552><B1551>EN</B1551><B1552>Bibliography</B1552><B1551>FR</B1551><B1552>Bibliographie</B1552></B155></B150><B190>EP</B190></B100><B200><B210>94916373.7</B210><B220><date>19940608</date></B220><B240><B241><date>19951223</date></B241><B242><date>19960607</date></B242></B240><B250>en</B250><B251EP>en</B251EP><B260>en</B260></B200><B300><B310>930432</B310><B320><date>19930608</date></B320><B330><ctry>IE</ctry></B330><B310>9410421</B310><B320><date>19940523</date></B320><B330><ctry>GB</ctry></B330></B300><B400><B405><date>20040908</date><bnum>200437</bnum></B405><B430><date>19960327</date><bnum>199613</bnum></B430><B450><date>20030917</date><bnum>200338</bnum></B450><B452EP><date>20030130</date></B452EP><B480><date>20040908</date><bnum>200437</bnum></B480></B400><B500><B510><B516>7</B516><B511> 7C 07D 473/18   A</B511></B510><B540><B541>de</B541><B542>O6-SUBSTITUIERTE GUANINEDERIVATE, VERFAHREN ZU IHRE HERSTELLUNG UND IHRE ANWENDUNG FÜR BEHANDLUNG VON TUMORZELLEN</B542><B541>en</B541><B542>06-SUBSTITUTED GUANINE DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND THEIR USE IN TREATING TUMOUR CELLS</B542><B541>fr</B541><B542>DERIVES DE GUANINE SUBSTITUEE EN POSTION 06, LEUR PROCEDE DE PREPARATION ET LEUR APPLICATION AU TRAITEMENT DES CELLULES TUMORALES</B542></B540><B560><B561><text>WO-A-91/13898</text></B561><B561><text>DE-A- 2 139 107</text></B561><B562><text>J. MED. CHEM. vol. 37, no. 3 , 4 February 1994 pages 342 - 347 M-Y CHAE ET AL 'Substituted O6-Benzylguanine derivatives and their inactivation of human O6-alkylguanine-DNA transferase' cited in the application</text></B562><B562><text>J. MED. CHEM. vol. 20, no. 3 , 1977 pages 341 - 344 A.P.MARTINEZ AT AL 'Potential Antitumour agents'</text></B562><B562><text>J. MED. CHEM. vol. 18, no. 10 , 1975 pages 968 - 973 B. PAUL ET AL 'Inhibiotrs of nucleoside transport'</text></B562></B560></B500><B700><B720><B721><snm>McMURRY, Thomas Brian Hamilton</snm><adr><str>The University Chem. Lab.,
Trinity College</str><city>Dublin 2</city><ctry>IE</ctry></adr></B721><B721><snm>McELHINNEY, Robert Stanley</snm><adr><str>The University Chem. Lab.,
Trinity College</str><city>Dublin 2</city><ctry>IE</ctry></adr></B721><B721><snm>McCORMICK, Joan Elizabeth</snm><adr><str>The University Chem. Lab.,
Trinity College</str><city>Dublin 2</city><ctry>IE</ctry></adr></B721><B721><snm>ELDER, Rhoderick, Hugh
c/o Christie Hospital</snm><adr><str>CRC Dept. of carcinogenesis, Paterson Inst.</str><city>Wilmslow Road, Manchester M20 9BX</city><ctry>GB</ctry></adr></B721><B721><snm>Kelly, Jane
Christie Hospital</snm><adr><str>CRC Dept. of Carcinogenesis, Paterson Inst.</str><city>Wilmslow Road, Manchester M20 9BX</city><ctry>GB</ctry></adr></B721><B721><snm>MARGISON, Geoffrey, Paul
CRC Dept. of Carcinog.</snm><adr><str>Paterson Institute
Christie Hospital</str><city>Wilmslow Road, Manchester M20 9BX</city><ctry>GB</ctry></adr></B721><B721><snm>RAFFERTY, Joseph, Anthony
CRC Dept. of Carcinog.</snm><adr><str>Paterson Institute
Christie Hospital</str><city>Wilmslow Road, Manchester M20 9BX</city><ctry>GB</ctry></adr></B721><B721><snm>WATSON, Amanda, Jean
CRC Dept. of Carcinog.</snm><adr><str>Paterson Institute
Cristie Hospital</str><city>Wilmslow Road, Manchester M20 9BX</city><ctry>GB</ctry></adr></B721><B721><snm>WILLINGTON, Mark, Andrew
CRC Dept. of Carcinog.</snm><adr><str>Paterson Institute
Christie Hospital</str><city>Wilmslow Road, Manchester M20 9BX</city><ctry>GB</ctry></adr></B721></B720><B730><B731><snm>Cancer Research Technology Limited</snm><iid>00474258</iid><irf>PK965EP</irf><adr><str>Cambridge House
6-10 Cambridge Terrace
Regent's Park</str><city>London NW1 4JL</city><ctry>GB</ctry></adr></B731></B730><B740><B741><snm>Parkes, Andrew John Aykroyd</snm><sfx>et al</sfx><iid>00034681</iid><adr><str>c/o Tomkins &amp; Co.
5 Dartmouth Road
Leeson Park</str><city>Dublin 6</city><ctry>IE</ctry></adr></B741></B740><B790><B791><dnum><text>0100</text></dnum><date>20030502</date><kind>E</kind><snm>KUDOS PHARMACEUTICALS LIMITED</snm><iid>00008310</iid><adr><str>327 Cambridge Science Park, Milton Road,</str><city>Cambridge CB4 1XL</city><ctry>GB</ctry></adr><B796><ctry>AT</ctry><ctry>BE</ctry><ctry>CH</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>ES</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>IE</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LU</ctry><ctry>MC</ctry><ctry>NL</ctry><ctry>PT</ctry><ctry>SE</ctry></B796></B791></B790></B700><B800><B840><ctry>AT</ctry><ctry>BE</ctry><ctry>CH</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>ES</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>IE</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LU</ctry><ctry>MC</ctry><ctry>NL</ctry><ctry>PT</ctry><ctry>SE</ctry></B840><B844EP><B845EP><ctry>SI</ctry><date>19951222</date></B845EP></B844EP><B860><B861><dnum><anum>IE1994000031</anum></dnum><date>19940608</date></B861><B862>en</B862></B860><B870><B871><dnum><pnum>WO1994029312</pnum></dnum><date>19941222</date><bnum>199428</bnum></B871></B870></B800></SDOBI>
</ep-patent-document>
